Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens-Kerim Ergüden

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 9, 2005
Novel, selective indole-based ECE inhibitors: lead optimization via solid-phase and classical synthesisMichael Brands, Jens-Kerim Ergüden, Kentaro Hashimoto, et al.
Chemmedchem|August 8, 2006
Selective indole-based ECE inhibitors: synthesis and pharmacological evaluationMichael Brands, Jens-Kerim Ergüden, Kentaro Hashimoto, et al.
Chemmedchem|February 28, 2018
Discovery of Molidustat (BAY 85-3934): A Small-Molecule Oral HIF-Prolyl Hydroxylase (HIF-PH) Inhibitor for the Treatment of Renal AnemiaHartmut Beck, Mario Jeske, Kai Thede, et al.
Chemmedchem|July 14, 2012
Discovery of BAY 94-8862: a nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseasesLars Bärfacker, Alexander Kuhl, Alexander Hillisch, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|August 9, 2005
Novel, selective indole-based ECE inhibitors: lead optimization via solid-phase and classical synthesisMichael Brands, Jens-Kerim Ergüden, Kentaro Hashimoto, et al.
Chemmedchem|August 8, 2006
Selective indole-based ECE inhibitors: synthesis and pharmacological evaluationMichael Brands, Jens-Kerim Ergüden, Kentaro Hashimoto, et al.
Chemmedchem|February 28, 2018
Discovery of Molidustat (BAY 85-3934): A Small-Molecule Oral HIF-Prolyl Hydroxylase (HIF-PH) Inhibitor for the Treatment of Renal AnemiaHartmut Beck, Mario Jeske, Kai Thede, et al.
Chemmedchem|July 14, 2012
Discovery of BAY 94-8862: a nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseasesLars Bärfacker, Alexander Kuhl, Alexander Hillisch, et al.
Pageof 1